Clinical Trials Browser

Phase 1 × NSCLC × Immune Checkpoint Inhibitors × Clear all

NCT05615142 2024-04-17

Safety and Tolerability of Low Dose Radiotherapy Concurrent SBRT and PD-1 Inhibitors in Advanced NSCLC.

Phase 1 Recruiting

NSCLC